
T Clop 75mg Tablet
Marketer
Vatican Life Sciences Pvt Ltd
Salt Composition
Clopidogrel (75mg)
Overview T Clop 75mg Tablet
CardioGuard 75mg tablets are antiplatelet agents, effectively reducing blood clot formation within blood vessels. This significantly lowers the risk of stroke and heart attack, making it a common preventative medication for cardiovascular health. CardioGuard 75mg is prescribed for individuals at elevated risk of heart disease, including those with peripheral artery disease (reduced blood flow from narrowed arteries), recent stroke or myocardial infarction, cardiac arrhythmias, and post-stent placement. It's also employed alongside other medications to manage heart attacks and unstable angina. This medication can be administered with or without food, consistently at the same time daily. Continued use is crucial; discontinuation raises the risk of stroke or heart attack. The most frequent adverse effect is bleeding, manifesting as bruising, epistaxis, hematuria, melena (dark stools), or heavier menstrual bleeding. Wound healing may be prolonged. While typically mild and self-limiting, persistent or concerning bleeding necessitates immediate medical attention. This medication is contraindicated for individuals with active internal bleeding, such as gastrointestinal ulcers or intracranial hemorrhage. Prior to commencing treatment, inform your physician of any history of bleeding disorders or recent major trauma or surgery. Temporary cessation may be necessary before scheduled surgeries or dental procedures.
Primary Ingredients of T Clop 75mg Tablet
The provided text is "undefined," offering no content to rephrase.
Uses of T Clop 75mg Tablet
Reducing the risk of cardiovascular events
Major Benefits of T Clop 75mg Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. T Clop 75mg Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of T Clop 75mg Tablet:
- Abdominal pain
- Bruise
- Diarrhea
- Hematoma
- Nosebleeds
- Gastrointestinal bleeding
- Dyspepsia
How to use T Clop 75mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment length. Ingest the 75mg T Clop tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or not, but consistent timing is recommended.
How T Clop 75mg Tablet works:
Ticlopidine 75mg tablets are antiplatelet agents that inhibit platelet aggregation, reducing the risk of dangerous thrombus development and consequently lowering the likelihood of myocardial infarction or cerebrovascular accident.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with T Clop 75mg Tablets requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of T Clop 75mg Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administration of T Clop 75mg tablets while breastfeeding appears to pose minimal risk. Available human data indicate negligible danger to the infant.
DrivingSAFE
Driving ability is typically unaffected by T Clop 75mg Tablets.
KidneySAFE IF PRESCRIBED
T Clop 75mg tablets can be administered to patients with kidney impairment without the need for dosage modification.
LiverSAFE IF PRESCRIBED
Patients with liver impairment can safely use T Clop 75mg tablets without requiring any dosage modification.
What if you forget to take T Clop 75mg Tablet :
Should you forget a T Clop 75mg Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About T Clop 75mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Amino acid alkyl esters |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Behavior Class | ADP receptor antagonists (P2Y12 inhibitors) |
